C3.ai (AI) 10-Q29 Feb 242024 Q3 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	9 Months Ended
Cover - shares	Jan. 31, 2024	Feb. 22, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jan. 31, 2024
Document Transition Report	false
Entity File Number	001-39744
Entity Registrant Name	C3.ai, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-3999357
Entity Address, Address Line One	1400 Seaport Blvd
Entity Address, City or Town	Redwood City,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94063
City Area Code	650
Local Phone Number	503-2200
Title of 12(b) Security	Class A Common Stock, par value $0.001 per share
Trading Symbol	AI
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Current Fiscal Year End Date	--04-30
Amendment Flag	false
Entity Central Index Key	0001577526
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		118,548,799
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		3,499,992

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Jan. 31, 2024	Apr. 30, 2023
Current assets
Cash and cash equivalents		$ 114,561	$ 284,829
Marketable securities		608,761	446,155
Accounts receivable, net of allowance of $359 and $359 as of January 31, 2024 and April 30, 2023, respectively	[1]	173,478	134,586
Prepaid expenses and other current assets	[2]	29,227	23,309
Total current assets		926,027	888,879
Property and equipment, net		91,003	84,578
Goodwill		625	625
Long-term marketable securities		0	81,418
Other assets, non-current	[3]	46,334	47,528
Total assets		1,063,989	1,103,028
Current liabilities
Accounts payable	[4]	19,845	24,610
Accrued compensation and employee benefits		37,822	46,513
Deferred revenue, current	[5]	39,121	47,846
Accrued and other current liabilities	[6]	12,391	17,070
Total current liabilities		109,179	136,039
Deferred revenue, non-current		2,183	4
Other long-term liabilities		54,632	37,320
Total liabilities		165,994	173,363
Commitments and contingencies (note 6)
Stockholders’ equity
Additional paid-in capital		1,914,450	1,740,174
Accumulated other comprehensive income (loss)		430	(385)
Accumulated deficit		(1,017,006)	(810,237)
Total stockholders’ equity		897,995	929,665
Total liabilities and stockholders’ equity		1,063,989	1,103,028
Class A Common Stock
Stockholders’ equity
Common stock		118	110
Class B Common Stock
Stockholders’ equity
Common stock		$ 3	$ 3

[1]Including amounts from a related party of $74,620 as of April 30, 2023.[2]Including amounts from a related party of $4,983 as of April 30, 2023.[3]Including amounts from a related party of $11,279 as of April 30, 2023.[4]Including amounts due to a related party of $2,200 as of April 30, 2023.[5]Including amounts from a related party of $249 as of April 30, 2023.[6]Including amounts due to a related party of $2,448 as of April 30, 2023.

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands		Jan. 31, 2024	Apr. 30, 2023
Accounts receivable, allowance		$ 359	$ 359
Accounts receivable, net, from related party	[1]	173,478	134,586
Prepaid expenses and other current assets, from related party	[2]	29,227	23,309
Other assets, non-current, due from related party	[3]	46,334	47,528
Accounts payable, from related party	[4]	19,845	24,610
Deferred revenue, current, from related party	[5]	39,121	47,846
Accrued and other current liabilities, from related party	[6]	$ 12,391	17,070
Related Party
Accounts receivable, net, from related party			74,620
Prepaid expenses and other current assets, from related party			4,983
Other assets, non-current, due from related party			11,279
Accounts payable, from related party			2,200
Deferred revenue, current, from related party			249
Accrued and other current liabilities, from related party			$ 2,448

[1]Including amounts from a related party of $74,620 as of April 30, 2023.[2]Including amounts from a related party of $4,983 as of April 30, 2023.[3]Including amounts from a related party of $11,279 as of April 30, 2023.[4]Including amounts due to a related party of $2,200 as of April 30, 2023.[5]Including amounts from a related party of $249 as of April 30, 2023.[6]Including amounts due to a related party of $2,448 as of April 30, 2023.

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Revenue
Total revenue		$ 78,401	$ 66,669	$ 223,992	$ 194,385
Cost of revenue
Total cost of revenue		33,114	22,271	97,043	61,429
Gross profit		45,287	44,398	126,949	132,956
Operating expenses
Sales and marketing	[1]	57,140	43,497	150,920	131,420
Research and development		49,480	55,051	150,747	160,979
General and administrative		21,213	17,888	61,317	57,770
Total operating expenses		127,833	116,436	362,984	350,169
Loss from operations		(82,546)	(72,038)	(236,035)	(217,213)
Interest income		9,995	6,987	30,597	13,749
Other income (expense), net		409	2,032	(468)	66
Loss before provision for income taxes		(72,142)	(63,019)	(205,906)	(203,398)
Provision for income taxes		489	143	863	485
Net loss		$ (72,631)	$ (63,162)	$ (206,769)	$ (203,883)
Net loss per share attributable to Class A and Class B common stockholders, basic (in dollars per share)		$ (0.60)	$ (0.57)	$ (1.75)	$ (1.87)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in dollars per share)		$ (0.60)	$ (0.57)	$ (1.75)	$ (1.87)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic (in shares)		120,486	110,735	118,259	108,869
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)		120,486	110,735	118,259	108,869
Subscription
Revenue
Total revenue	[2]	$ 70,400	$ 57,043	$ 198,201	$ 173,577
Cost of revenue
Total cost of revenue		32,273	21,294	93,644	54,551
Professional services
Revenue
Total revenue	[3]	8,001	9,626	25,791	20,808
Cost of revenue
Total cost of revenue		$ 841	$ 977	$ 3,399	$ 6,878

[1]Including related party sales and marketing expense of $810 and $10,546 for the nine months ended January 31, 2024 and 2023, respectively, and $3,515 for the three months ended January 31, 2023.[2]Including related party revenue of $10,581 and $55,884 for the nine months ended January 31, 2024 and 2023, respectively, and $20,316 for the three months ended January 31, 2023.[3]Including related party revenue of $5,804 and $8,749 for the nine months ended January 31, 2024 and 2023, respectively, and $8,599 for the three months ended January 31, 2023.

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Related party revenue		$ 78,401	$ 66,669	$ 223,992	$ 194,385
Related party sales and marketing	[1]	57,140	43,497	150,920	131,420
Related Party
Related party sales and marketing			3,515	810	10,546
Subscription
Related party revenue	[2]	70,400	57,043	198,201	173,577
Subscription \| Related Party
Related party revenue			20,316	10,581	55,884
Professional services
Related party revenue	[3]	$ 8,001	9,626	25,791	20,808
Professional services \| Related Party
Related party revenue			$ 8,599	$ 5,804	$ 8,749

[1]Including related party sales and marketing expense of $810 and $10,546 for the nine months ended January 31, 2024 and 2023, respectively, and $3,515 for the three months ended January 31, 2023.[2]Including related party revenue of $10,581 and $55,884 for the nine months ended January 31, 2024 and 2023, respectively, and $20,316 for the three months ended January 31, 2023.[3]Including related party revenue of $5,804 and $8,749 for the nine months ended January 31, 2024 and 2023, respectively, and $8,599 for the three months ended January 31, 2023.

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (72,631)	$ (63,162)	$ (206,769)	$ (203,883)
Other comprehensive income
Unrealized gain on available-for-sale marketable securities, net of tax	1,205	1,770	815	1,113
Comprehensive loss	$ (71,426)	$ (61,392)	$ (205,954)	$ (202,770)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	RSUs	Common Stock	Common Stock RSUs	Additional Paid-In Capital	Additional Paid-In Capital RSUs	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning Balance, shares (in shares) at Apr. 30, 2022			106,225
Beginning Balance, Amount at Apr. 30, 2022	$ 989,477		$ 106		$ 1,532,917		$ (2,148)	$ (541,398)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)			747
Issuance of Class A common stock upon exercise of stock options, net of repurchases	2,387		$ 1		2,386
Vesting of early exercised Class A common stock options	842				842
Shares withheld related to net share settlement of equity awards (in shares)			(336)
Shares withheld related to net share settlement of equity awards	(4,815)				(4,815)
Vesting of restricted stock units (in shares)				5,373
Vesting of restricted stock units		$ 23,928		$ 5		$ 23,923
Stock-based compensation expense	138,321				138,321
Other comprehensive income	1,113						1,113
Net loss	(203,883)							(203,883)
Ending Balance, shares (in shares) at Jan. 31, 2023			112,009
Ending Balance, Amount at Jan. 31, 2023	947,370		$ 112		1,693,574		(1,035)	(745,281)
Beginning Balance, shares (in shares) at Oct. 31, 2022			110,101
Beginning Balance, Amount at Oct. 31, 2022	953,166		$ 110		1,637,980		(2,805)	(682,119)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)			180
Issuance of Class A common stock upon exercise of stock options, net of repurchases	590				590
Vesting of early exercised Class A common stock options	286				286
Shares withheld related to net share settlement of equity awards (in shares)			(115)
Shares withheld related to net share settlement of equity awards	(1,440)				(1,440)
Vesting of restricted stock units (in shares)				1,843
Vesting of restricted stock units		10,255		$ 2		10,253
Stock-based compensation expense	45,905				45,905
Other comprehensive income	1,770						1,770
Net loss	(63,162)							(63,162)
Ending Balance, shares (in shares) at Jan. 31, 2023			112,009
Ending Balance, Amount at Jan. 31, 2023	947,370		$ 112		1,693,574		(1,035)	(745,281)
Beginning Balance, shares (in shares) at Apr. 30, 2023			113,943
Beginning Balance, Amount at Apr. 30, 2023	$ 929,665		$ 113		1,740,174		(385)	(810,237)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)	2,535		2,534
Issuance of Class A common stock upon exercise of stock options, net of repurchases	$ 11,319		$ 2		11,317
Vesting of early exercised Class A common stock options	406				406
Shares withheld related to net share settlement of equity awards (in shares)			(283)
Shares withheld related to net share settlement of equity awards	(10,485)				(10,485)
Vesting of restricted stock units (in shares)				5,004
Vesting of restricted stock units		34,475		$ 5		34,470
Issuance of Class A common stock under employee stock purchase plan (in shares)			429
Issuance of Class A common stock under employee stock purchase plan	5,055		$ 1		5,054
Stock-based compensation expense	133,514				133,514
Other comprehensive income	815						815
Net loss	(206,769)							(206,769)
Ending Balance, shares (in shares) at Jan. 31, 2024			121,627
Ending Balance, Amount at Jan. 31, 2024	897,995		$ 121		1,914,450		430	(1,017,006)
Beginning Balance, shares (in shares) at Oct. 31, 2023			119,653
Beginning Balance, Amount at Oct. 31, 2023	911,276		$ 119		1,856,307		(775)	(944,375)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options, net of repurchases (in shares)			283
Issuance of Class A common stock upon exercise of stock options, net of repurchases	1,209				1,209
Vesting of early exercised Class A common stock options	112				112
Shares withheld related to net share settlement of equity awards (in shares)			(30)
Shares withheld related to net share settlement of equity awards	(720)				(720)
Vesting of restricted stock units (in shares)				1,721
Vesting of restricted stock units		$ 13,006		$ 2		$ 13,004
Stock-based compensation expense	44,538				44,538
Other comprehensive income	1,205						1,205
Net loss	(72,631)							(72,631)
Ending Balance, shares (in shares) at Jan. 31, 2024			121,627
Ending Balance, Amount at Jan. 31, 2024	$ 897,995		$ 121		$ 1,914,450		$ 430	$ (1,017,006)

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands		9 Months Ended
		Jan. 31, 2024	Jan. 31, 2023
Cash flows from operating activities:
Net loss		$ (206,769)	$ (203,883)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization		9,469	3,257
Non-cash operating lease cost		656	5,820
Stock-based compensation expense		159,032	168,474
Accretion of discounts on marketable securities		(13,238)	(1,990)
Other		110	211
Changes in operating assets and liabilities
Accounts receivable	[1]	(38,892)	(63,609)
Prepaid expenses, other current assets and other assets	[2]	(3,379)	(7,745)
Accounts payable	[3]	(4,945)	(26,250)
Accrued compensation and employee benefits		171	1,069
Operating lease liabilities		14,330	(3,296)
Other liabilities	[4]	6,296	(4,606)
Deferred revenue	[5]	(6,546)	(10,197)
Net cash used in operating activities		(83,705)	(142,745)
Cash flows from investing activities:
Purchases of property and equipment		(22,718)	(59,767)
Capitalized software development costs		(2,750)	(1,000)
Purchases of marketable securities		(657,431)	(497,288)
Maturities and sales of marketable securities		590,299	674,440
Net cash (used in) provided by investing activities		(92,600)	116,385
Cash flows from financing activities:
Proceeds from issuance of Class A common stock under employee stock purchase plan		5,055	0
Proceeds from exercise of Class A common stock options		11,379	2,364
Taxes paid related to net share settlement of equity awards		(10,397)	(4,815)
Net cash provided by (used in) financing activities		6,037	(2,451)
Net decrease in cash, cash equivalents and restricted cash		(170,268)	(28,811)
Cash, cash equivalents and restricted cash at beginning of period		297,395	352,519
Cash and cash equivalents		114,561	311,142
Restricted cash included in other assets, non-current		12,566	12,566
Cash, cash equivalents and restricted cash at end of period		127,127	323,708
Total cash, cash equivalents and restricted cash		127,127	323,708
Supplemental disclosure of cash flow information—cash paid for income taxes		760	219
Supplemental disclosures of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable and accrued liabilities		2,475	12,618
Right-of-use assets obtained in exchange for lease obligations (including remeasurement of right-of-use assets and lease liabilities due to changes in the timing of receipt of lease incentives)		1,858	2,033
Unpaid liabilities related to intangible purchases		0	1,500
Vesting of early exercised stock options		$ 406	$ 842

[1] Including changes in related party balances of $12,444 and $46,295 for the nine months ended January 31, 2024 and 2023, respectively. Including changes in related party balances of $(810) and $(3,525) for the nine months ended January 31, 2024 and 2023, respectively. Including changes in related party balances of $248 and $(18,549) for the nine months ended January 31, 2024 and 2023, respectively. Including changes in related party balances of $(2,448) and $(2,510) for the nine months ended January 31, 2024 and 2023, respectively. Including changes in related party balances of $(46) and $186 for the nine months ended January 31, 2024 and 2023, respectively.

CONDENSED CONSOLIDATED STATEM_6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Thousands		9 Months Ended
		Jan. 31, 2024	Jan. 31, 2023
Related party balanced included in prepaid expenses, other current assets and other assets	[1]	$ 3,379	$ 7,745
Related party balances included in other liabilities	[2]	6,296	(4,606)
Related Party
Related party balances included in accounts receivable		12,444	46,295
Related party balanced included in prepaid expenses, other current assets and other assets		(810)	(3,525)
Related party balances included in accounts payable		248	(18,549)
Related party balances included in other liabilities		(2,448)	(2,510)
Related party balance included in deferred revenue		$ (46)	$ 186

[1] Including changes in related party balances of $(810) and $(3,525) for the nine months ended January 31, 2024 and 2023, respectively. Including changes in related party balances of $(2,448) and $(2,510) for the nine months ended January 31, 2024 and 2023, respectively.

Summary of Business and Signifi

Summary of Business and Significant Accounting Policies	9 Months Ended
Summary of Business and Significant Accounting Policies	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Business and Significant Accounting Policies	Summary of Business and Significant Accounting Policies Business C3.ai, Inc. (including its subsidiaries, “C3 AI” or “the Company”) is an enterprise artificial intelligence (“AI”) software provider. The Company’s C3 AI Platform supports accelerating digital transformation in various industries with prebuilt and configurable C3 AI Applications for business use cases including predictive maintenance, fraud detection, sensor network health, supply network optimization, energy management, anti-money laundering, and customer engagement. The Company supports customers in the United States, Europe, and other parts of the world. The Company was initially formed as a limited liability company in Delaware on January 8, 2009 and converted to a Delaware corporation in June 2012. Basis of Presentation and Principles of Consolidation The Company prepares its unaudited condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2023, which was filed with the SEC on June 22, 2023. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the Company’s financial position as of January 31, 2024 and the results of operations for the three and nine months ended January 31, 2024. The results of operations for the three and nine months ended January 31, 2024 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the accompanying unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include, but are not limited to, determining standalone selling price for performance obligations in contracts with customers and estimating variable consideration, the estimated expected benefit period for deferred contract acquisition costs, the useful lives of long-lived assets, the incremental borrowing rate for operating leases, other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. Fiscal Year The Company’s fiscal year ends on April 30. Summary of Significant Accounting Policies The Company’s significant accounting policies are discussed in Note 1. Summary of Business and Significant Accounting Policies in the Notes to Consolidated Financial Statements in its Annual Report on Form 10-K for the fiscal year ended April 30, 2023, which was filed with the SEC on June 22, 2023. There have been no significant changes to these policies during the three and nine months ended January 31, 2024. Recently Issued Accounting Standards Not Yet Adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”) to improve the disclosures regarding a public entity’s reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The Company is required to adopt the guidance in the fourth quarter of fiscal 2025, though early adoption is permitted. The Company is currently evaluating the impact of this amendment on its Consolidated Financial Statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures (“ASU 2023-09”) to provide disaggregated income tax disclosures on rate reconciliation and income taxes paid. The Company is required to adopt the guidance in the fourth quarter of fiscal 2026, though early adoption is permitted. The Company is currently evaluating the impact of this amendment on its Consolidated Financial Statements.

Revenue

Revenue	9 Months Ended
Revenue	Jan. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Disaggregation of Revenue The following table presents revenue by geographical region (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 North America (1) $ 68,356 $ 55,254 $ 191,247 $ 155,108 Europe, the Middle East and Africa (1) 9,040 9,546 29,205 32,138 Asia Pacific (1) 952 1,801 2,877 6,603 Rest of World (1) 53 68 663 536 Total revenue $ 78,401 $ 66,669 $ 223,992 $ 194,385 __________________ (1) The United States comprised 86% and 83% of the Company’s revenue for the three months ended January 31, 2024 and 2023, respectively, and 85% and 80% of the Company’s revenue for the nine months ended January 31, 2024 and 2023, respectively. No other country comprised 10% or greater of the Company’s revenue for the three and nine months ended January 31, 2024 or 2023. Deferred Revenue As of January 31, 2024 and April 30, 2023, the Company’s deferred revenue balances were $41.3 million and $47.9 million, respectively. Revenue of $46.3 million and $45.6 million was recognized during the nine months ended January 31, 2024 and 2023, respectively, that was included in the deferred revenue balances as of April 30, 2023 and 2022, respectively. Remaining Performance Obligation Remaining performance obligations are committed and represent non-cancellable contracted revenue that has not yet been recognized and will be recognized as revenue in future periods. Some contracts allow customers to cancel the contracts without a significant penalty, and the cancellable amount of contract value is not included in the remaining performance obligations. The Company excludes amounts related to performance obligations and usage-based royalties that are billed and recognized as they are delivered or billed and recognized in the same period. This primarily consists of monthly usage-based runtime and hosting charges in the duration of some revenue contracts. Revenue expected to be recognized from remaining performance obligations was approximately $286.9 million as of January 31, 2024, of which $172.0 million is expected to be recognized over the next 12 months and the remainder thereafter. Customer Concentration and Accounts Receivable A majority of the Company’s Customer-Entities consist of corporate and governmental entities. A Customer-Entity is defined as each entity that is the ultimate parent of a party contracting with the Company. A limited number of Customer-Entities have accounted for a large part of the Company’s revenue and accounts receivable to date. For the purpose of determining customer concentration and accounts receivable, unbilled receivables have been excluded from the accounts receivable balance. Two separate Customer-Entities accounted for 25% and 12%, respectively, of revenue for the three months ended January 31, 2024. One Customer-Entity accounted for 45% of revenue for the three months ended January 31, 2023. Two separate Customer-Entities accounted for 27% and 13%, respectively, of revenue for the nine months ended January 31, 2024. One Customer-Entity accounted for 34% of revenue for the nine months ended January 31, 2023. Two separate Customer-Entities accounted for 18% and 14%, respectively, of accounts receivable at January 31, 2024. Two separate Customer-Entities accounted for 20% and 18%, respectively, of accounts receivable at April 30, 2023. Accounts receivable includes billed and unbilled receivables, net of allowance of doubtful accounts. Trade accounts receivable are recorded at invoiced amounts and do not bear interest. The allowance for credit losses is based on the Company’s assessment of the collectability of accounts receivable by considering various factors, including the age of each outstanding invoice, customer type, the collection history of each customer, historical write-off experience, current and near-term macroeconomic conditions and uncertainties. The expectation of collectability is based on a review of credit profiles of customers, contractual terms and conditions, current economic trends, and historical payment experience. Accounts receivable included unbilled receivables as of January 31, 2024 and April 30, 2023 of $102.6 million and $77.6 million, respectively.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Jan. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company’s financial instruments consist primarily of cash equivalents, restricted cash, available-for-sale marketable securities, accounts receivable, and accounts payable. Cash equivalents and available-for-sale marketable securities are reported at their respective fair values on the condensed consolidated balance sheets. The remaining financial instruments are reported on the condensed consolidated balance sheets at amounts that approximate current fair values. The following table summarizes the types of assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands): As of January 31, 2024 As of April 30, 2023 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 78,747 $ — $ — $ 78,747 $ 75,293 $ — $ — $ 75,293 Certificates of deposit — 3,500 — 3,500 — 2,000 — 2,000 Commercial paper — 8,925 — 8,925 — 112,851 — 112,851 Corporate debt securities — 1,893 — 1,893 — — — — Available-for-sale marketable securities: U.S. treasury securities — 7,455 — 7,455 — 27,397 — 27,397 Certificates of deposit — 65,514 — 65,514 — 61,025 — 61,025 U.S. government agencies securities — 57,763 — 57,763 — 75,674 — 75,674 Commercial paper — 161,222 — 161,222 — 184,230 — 184,230 Corporate debt securities — 316,807 — 316,807 — 179,247 — 179,247 Total cash equivalents and available-for-sale marketable securities $ 78,747 $ 623,079 $ — $ 701,826 $ 75,293 $ 642,424 $ — $ 717,717 The estimated fair value of securities classified as Level 2 financial instruments was determined based on third-party pricing services. The pricing services utilize industry standard valuation models, including both income- and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. Inputs used for fair value measurement categorized as Level 2 include benchmark yields, reported trades, broker or dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications.

Cash Equivalents and Marketable

Cash Equivalents and Marketable Securities	9 Months Ended
Cash Equivalents and Marketable Securities	Jan. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Marketable Securities	Cash Equivalents and Marketable Securities The following table summarizes the Company’s cash equivalents and available-for-sale marketable securities (in thousands): As of January 31, 2024 As of April 30, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cash equivalents: Money market funds $ 78,747 $ — $ — $ 78,747 $ 75,293 $ — $ — $ 75,293 Certificates of deposit 3,500 — — 3,500 2,000 — — 2,000 Commercial paper 8,925 — — 8,925 112,851 — — 112,851 Corporate debt securities 1,893 — — 1,893 — — — — Available-for-sale marketable securities: U.S. treasury securities 7,454 1 — 7,455 27,445 1 (49) 27,397 Certificates of deposit 65,514 — — 65,514 61,025 — — 61,025 U.S. government agencies securities 57,629 147 (13) 57,763 75,650 111 (87) 75,674 Commercial paper 161,222 — — 161,222 184,230 — — 184,230 Corporate debt securities 316,512 450 (155) 316,807 179,608 115 (476) 179,247 Total cash equivalents and available-for-sale marketable securities $ 701,396 $ 598 $ (168) $ 701,826 $ 718,102 $ 227 $ (612) $ 717,717 The Company considers all of its marketable securities as available for use in current operations, including those with maturity dates beyond one year, and therefore classifies these securities within current assets on the Condensed Consolidated Balance Sheet as of January 31, 2024. The following table summarizes the Company’s available-for-sale marketable securities by contractual maturity (in thousands): As of January 31, 2024 As of April 30, 2023 Amortized Cost Fair Value Amortized Cost Fair Value Within one year $ 518,581 $ 518,683 $ 446,629 $ 446,155 After one year through five years 89,750 90,078 81,329 81,418 Total $ 608,331 $ 608,761 $ 527,958 $ 527,573 The following table summarizes the fair values and unrealized losses of the Company’s available-for-sale marketable securities classified by length of time that the securities have been in a continuous unrealized loss position but were not deemed to be other-than-temporarily impaired, as of January 31, 2024 (in thousands): As of January 31, 2024 Less Than 12 Months 12 Months or Greater Total Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value U.S. government agencies securities $ (9) $ 17,968 $ (4) $ 2,362 $ (13) $ 20,330 Commercial paper — 5,953 — — — 5,953 Corporate debt securities (133) 120,053 (22) 10,710 (155) 130,763 Total $ (142) $ 143,974 $ (26) $ 13,072 $ (168) $ 157,046

Balance Sheet Details

Balance Sheet Details	9 Months Ended
Balance Sheet Details	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Details	Balance Sheet Details Property and Equipment, Net Property and equipment consisted of the following at January 31, 2024 and April 30, 2023 (in thousands): Useful Life As of January 31, As of April 30, (in months) 2024 2023 Leasehold improvements * $ 71,703 $ 66,522 Computer equipment 36 5,620 4,901 Office furniture and equipment 60 14,494 14,343 Capital in progress NA 12,042 3,140 Property and equipment, gross 103,859 88,906 Less: accumulated depreciation and amortization (12,856) (4,328) Property and equipment, net $ 91,003 $ 84,578 __________________ * Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term. NA = Not Applicable Capital in progress primarily consisted of costs related to various leasehold improvements in connection with leased space that is not considered available for use and has not yet been placed into service. Depreciation and amortization expense related to property and equipment was $2.9 million and $0.5 million for the three months ended January 31, 2024 and 2023, respectively, and $8.5 million and $2.4 million for the nine months ended January 31, 2024 and 2023, respectively. Accrued Compensation and Employee Benefits Accrued compensation and employee benefits consisted of the following at January 31, 2024 and April 30, 2023 (in thousands): As of January 31, As of April 30, 2024 2023 Accrued stock-settled bonus $ 21,522 $ 32,414 Accrued bonus 296 186 Accrued vacation 3,948 4,602 Accrued payroll taxes and benefits 3,166 3,975 Accrued commissions 3,181 2,889 Accrued salaries 414 206 ESPP contributions 4,383 1,339 Other 912 902 Accrued compensation and employee benefits $ 37,822 $ 46,513 Accrued and Other Current Liabilities Accrued and other current liabilities consisted of the following at January 31, 2024 and April 30, 2023 (in thousands): As of January 31, As of April 30, 2024 2023 Liability for common stock exercised prior to vesting $ 385 $ 799 Accrued general expenses 3,131 5,541 Operating lease liabilities, current 2,936 2,339 Accrued professional services 2,286 2,889 Commissions payable to a related party — 2,448 Other 3,653 3,054 Accrued and other current liabilities $ 12,391 $ 17,070

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Jan. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Non-cancellable Purchase Commitments The Company entered into a non-cancellable arrangement with a cloud services provider in July 2022. Under the arrangement, the Company committed to spend an aggregate of at least $100.0 million for a period of three years beginning July 2022, on services with this vendor. The Company has incurred costs totaling $7.7 million and $2.3 million during the three months ended January 31, 2024 and 2023, respectively, and $23.5 million and $3.9 million during the nine months ended January 31, 2024 and 2023, respectively, under the arrangement. The Company entered into a non-cancellable arrangement with a professional services provider in October 2023. Under the arrangement, the Company committed to purchase an aggregate of $15.0 million of professional services for a period of 18 months beginning October 2023. The Company has incurred costs totaling $0.2 million and $0.2 million during the three and nine months ended January 31, 2024, respectively, under the arrangement. The Company entered into a non-cancellable arrangement with a professional services provider in January 2024. Under the arrangement, the Company committed to purchase an aggregate of $13.0 million of professional services for a period of one year beginning January 2024. The Company has incurred costs totaling $0.7 million and $1.2 million during the three and nine months ended January 31, 2024, respectively, under the arrangement. C3.ai Digital Transformation Institute Grants In February 2020, the Company entered into an agreement establishing the C3.ai Digital Transformation Institute (“C3.ai DTI”), a program established to attract many of the world’s leading research institutions to join in a coordinated and innovative effort to advance the digital transformation of business, government, and society. As part of the agreement, the Company has agreed to issue grants to C3.ai DTI, which are subject to compliance with certain obligations. The grants shall be paid by the Company over five years in the form of cash, publicly traded securities, or other property of equivalent net value. As of January 31, 2024 and April 30, 2023, the total potential remaining contributions are $31.6 million and $31.6 million, respectively. The future grant payments are conditional in nature and subject to execution of the program in line with specific requirements. Leases On August 25, 2021, the Company entered into a new lease to acquire approximately 283,015 square feet of office space in several phases in Redwood City, California. The lease commencement date of the first two phases was determined to have occurred in the quarter ended January 31, 2022, when the landlord delivered the leased space to the Company. The lease commencement date of the third phase was determined to have occurred in the quarter ended October 31, 2022, when the landlord delivered the leased space to the Company. During the quarter ended July 31, 2023, there was a remeasurement of right-of-use assets and lease liabilities related to the third phase of the lease due to changes in the timing of receipt of lease incentives. As a result, the lease liability was reduced to $2.0 million and corresponding right-of-use asset was reduced to $1.7 million. The lease commencement date of the fourth phase was determined to have occurred in the quarter ended April 30, 2023, when the landlord delivered the leased space to the Company. The lease commencement date of the fifth phase was determined to have occurred in the quarter ended July 31, 2023, when the landlord delivered the leased space to the Company. The Company recorded $1.6 million of lease liability in other long-term liabilities and corresponding right-of-use asset in other assets, non-current in the condensed consolidated balance sheets related to the fifth phase of the lease. During the quarter ended January 31, 2024, there was a remeasurement of right-of-use assets and lease liabilities related to phases one to five of the lease due to changes in the timing of receipt of lease incentives. As a result, the lease liability for these phases was reduced to $47.4 million and corresponding right-of-use asset for these phases was reduced to $17.2 million. The lease commencement date of the sixth phase was determined to have occurred in the quarter ended January 31, 2024, when the landlord delivered the leased space to the Company. The Company recorded $1.7 million of lease liability in other long-term liabilities and corresponding right-of-use asset in other assets, non-current in the condensed consolidated balance sheets related to the sixth phase of the lease. The lease commencement date of the seventh phase will be determined when the landlord delivers the applicable leased space to the Company. Legal Proceedings Securities Litigation On March 4, 2022, a putative securities class action complaint (captioned The Reckstin Family Trust v. C3.ai, Inc. et al. , 22-cv-01413-HSG) was filed in the U.S. District Court for the Northern District of California against the Company, and certain current and former officers and directors. On December 12, 2022, the court appointed a lead plaintiff and lead counsel. On February 15, 2023, the lead plaintiff and three additional named plaintiffs filed an amended complaint. The amended complaint names as defendants the Company, four current and former officers and directors, the underwriters in the Company’s initial public offering (“IPO”), and Baker Hughes Company (“Baker Hughes”). The amended complaint generally alleges that the defendants made material misstatements or omissions about the Company’s partnership with Baker Hughes and the Company’s own salesforce. The amended complaint alleges that defendants made these misstatements or omissions in connection with the Company’s IPO in violation of Sections 11 and 15 of the Securities Act of 1933 and between December 9, 2020 and December 2, 2021, inclusive, in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The amended complaint further alleges that certain defendants engaged in insider trading in violation of Section 20A of the Securities Exchange Act of 1934. Plaintiffs seek unspecified damages, interest, fees and costs. All defendants moved to dismiss Plaintiffs’ amended complaint on May 1, 2023. On June 30, 2023, Plaintiffs voluntarily dismissed the underwriter defendants. On February 22, 2024, the Court granted the motion to dismiss on all claims except for portions of the alleged violations of Section 11 and Section 15. Plaintiffs have until March 14, 2024 to amend their complaint. Three putative shareholder derivative actions have been filed: (1) Suri v. Siebel et al. (22-cv-03031) filed on May 23, 2022 in the U.S. District Court for the Northern District of California; (2) Rabasca v. Siebel et al. (23-cv-1566) filed on April 3, 2023 in the U.S. District Court for the Northern District of California; and (3) Vo v. Siebel et al. (23-cv-428) filed on April 19, 2023 in the U.S. District Court for the District of Delaware. In these cases, the plaintiffs assert claims on the Company’s behalf against certain of the Company’s current and former officers and directors for breach of fiduciary duty, aiding and abetting breach of fiduciary duty, gross mismanagement, corporate waste, abuse of control, unjust enrichment, and violations of the Securities Exchange Act of 1934 based on allegations similar to those in the securities class action. In all three cases, the Company is named as a nominal defendant. The derivative complaints seek unspecified damages, disgorgement of profits from board member stock sales, an award of costs and expenses, including reasonable attorneys’ fees, and corporate governance reforms. On September 7, 2022, Suri was stayed pending resolution of the Reckstin case. On August 3, 2023, Vo was transferred to the U.S. District Court for the Northern District of California (3:23-cv-03895), and on August 30, 2023 the Vo action was stayed on the same terms as the Suri action. On December 4, 2023, the parties in Rabasca filed a stipulation to consolidate the Rabasca action with the Suri action, and to stay the Rabasca action on the same terms as the Suri action. The Company has not yet been required to answer the Complaints in Suri , Rabasca and Vo . As of the date of this report, the Company does not believe it is probable that these cases will result in an unfavorable outcome; however, if an unfavorable outcome were to occur in these cases, it is possible that the impact could be material to the Company’s results of operations in the period(s) in which any such outcome becomes probable and estimable. A reasonable estimate of the amount of any possible loss or range of loss cannot be made at this time. In addition, from time to time, the Company is involved in various other legal proceedings arising in the ordinary course of business. Apart from the foregoing, the Company is not presently a party to any other such litigation the outcome of which, the Company believes, if determined adversely to the Company, would individually, or taken together, have a material adverse effect on the Company’s business, operating results, cash flows, or financial condition.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
Stockholders' Equity	Jan. 31, 2024
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Preferred Stock The Company has authorized 200,000,000 shares of undesignated preferred stock with a par value of $0.001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors. As of January 31, 2024, there were no shares of Preferred Stock issued or outstanding. Common Stock The Company has authorized 1,000,000,000 shares of Class A common stock and 3,500,000 shares of Class B common stock. The shares of Class A common stock and Class B common stock are identical, except with respect to voting, conversion, and transfer rights. Each share of Class A common stock is entitled to one vote. Each share of Class B common stock is entitled to 50 votes. Class A and Class B common stock have a par value of $0.001 per share and are referred to as common stock throughout the notes to the unaudited condensed consolidated financial statements, unless otherwise noted. Holders of common stock are entitled to receive any dividends as may be declared from time to time by the board of directors. Shares of Class B common stock may be converted to Class A common stock at any time at the option of the stockholder. Each share of Class B common stock will be automatically converted into one share of Class A common stock upon the earliest of the following: (i) the date that is six months following the death or incapacity of Mr. Siebel; (ii) the date that is six months following the date that Mr. Siebel is no longer providing services to the Company as an officer, employee, director, or consultant; (iii) December 11, 2040, which is the twentieth anniversary of the completion of the IPO; or (iv) the date specified by the holders of a majority of the then outstanding shares of Class B common stock, voting as a separate class. Future transfers by holders of Class B common stock will generally result in those shares converting to Class A common stock. Common Stock Subject to Repurchase Under the Company’s Amended and Restated 2012 Equity Incentive Plan (the “2012 Incentive Plan”) and the Company’s Amended and Restated 2020 Equity Incentive Plan (the “2020 Incentive Plan”), certain optionholders are allowed to exercise stock options to purchase Class A common stock prior to vesting. The Company has the right to repurchase at the original purchase price any unvested but outstanding shares of common stock upon termination of service of the optionholder. The consideration received for an early exercise of a stock option is considered to be a deposit of the exercise price and the related amount is recorded as a liability. There have been no net proceeds from the early exercise of such options during the three and nine months ended January 31, 2024 and 2023. The liability is reclassified into equity on a ratable basis as the stock options vest. Unvested Class A common stock of 65,730 and 148,239 shares as of January 31, 2024 and April 30, 2023, respectively, were subject to such repurchase right and are legally issued and outstanding as of each period presented. See Note 8. Stock-Based Compensation for more information. Stock Repurchase Program In December 2021, the Company’s board of directors approved a stock repurchase program for the repurchase of up to $100.0 million of the Company’s outstanding shares of Class A common stock for the 18 months following the date of such approval. Under the program, the Company may purchase stock in the open market or through privately negotiated transactions in accordance with applicable securities laws. The timing and actual amount of the stock repurchases will depend on several factors including price, capital availability, regulatory requirements, alternative investment opportunities and other market conditions. In March 2022, the Company repurchased and immediately retired 0.7 million shares of its Class A common stock for an aggregate amount of $15.0 million. The Company had not repurchased any shares of its Class A common stock under this program during the fiscal year 2024. The stock repurchase program expired in June 2023.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
Stock-Based Compensation	Jan. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation On November 27, 2020, the Company’s board of directors adopted, and its stockholders approved, the 2020 Incentive Plan, which became effective in connection with the IPO. The 2020 Incentive Plan provides for the grant of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit (“RSU”) awards, performance awards and other equity awards. On August 15, 2023 and August 21, 2023, respectively, the Company’s compensation committee and our board of directors adopted, and on October 4, 2023, its stockholders approved, the amendment of the 2020 Incentive Plan to increase the maximum number of shares of Class A common stock that may be automatically added to the share reserve of the 2020 Incentive Plan on May 1 of each year from May 1, 2024 until (and including) May 1, 2030 pursuant to the “evergreen” provision of the 2020 Incentive Plan from five percent (5%) to seven percent (7%) of the total number of shares of the Company’s Class A common stock and Class B common stock outstanding on April 30 of the immediately preceding fiscal year. Prior to the adoption and approval of such amendment, there was an automatic annual increase on May 1, 2023 in the number of shares reserved for future issuance pursuant to the 2020 Incentive Plan in an amount equal to five percent (5%) of the total number of shares of the Company’s Class A common stock and Class B common stock outstanding as of April 30, 2023. Stock Options Stock options generally expire 10 years from the date of grant, or earlier if services are terminated. Generally, each stock option for common stock is subject to a vesting schedule such that one fifth of the award vests after the first-year anniversary and one-sixtieth of the award vests each month thereafter over the remaining four years, subject to continuous service. A summary of the Company’s option activity during the nine months ended January 31, 2024 is as follows: Options Outstanding Number of Weighted Weighted Aggregate (in thousands) (in thousands) Balance as of April 30, 2023 34,696 $ 12.75 6.45 $ 175,907 Options granted 829 30.11 Options exercised (2,535) 34.48 Options cancelled (953) 10.74 Balance as of January 31, 2024 32,037 $ 13.91 5.90 $ 348,241 Vested and exercisable as of January 31, 2024 23,395 $ 10.30 5.42 $ 338,766 Vested and expected to vest as of January 31, 2024 (1) 32,103 $ 13.91 5.90 $ 348,956 __________________ (1) The number of options vested and expected to vest as of January 31, 2024 includes early exercised, unvested Class A common stock. Refer to Note 7. Stockholders’ Equity for more information. As of January 31, 2024, there was $90.8 million of unrecognized compensation cost related to stock options which is expected to be recognized over an estimated weighted-average period of 2.5 years. The grant-date fair value of the options issued for the nine months ended January 31, 2024 is estimated on the date of grant using the Black-Scholes-Merton option pricing model. The weighted average assumptions underlying the fair value estimation are provided in the following table: Nine Months Ended January 31, 2024 2023 Valuation assumptions: Expected dividend yield — % — % Expected volatility 63.5 % 46.2 % Expected term (years) 6.0 6.5 Risk-free interest rate 3.9 % 3.8 % Restricted Stock Units The Company’s RSUs include time-based RSUs and performance-based RSUs with market conditions (“PRSUs”). Time-based RSUs The time-based RSUs are typically subject to service-based vesting conditions satisfied over five years with one-fifth of the award vesting after the first-year anniversary and one-twentieth of the award vesting quarterly thereafter. The related stock-based compensation is recognized on a straight-line basis over the requisite service period. PRSUs In July 2022, the compensation committee of the board of directors (the “Compensation Committee”) approved the grant of a maximum of 1,700,000 performance-based restricted stock units (the “PRSU Award”) to the CEO pursuant to the 2020 Incentive Plan, subject to and conditioned upon the subsequent determination by the board of directors of performance metrics upon the achievement of which the PRSU Award would vest. In August 2022, the board of directors approved performance metrics in concept, subject to further action by the Compensation Committee. In December 2022, the Compensation Committee: (a) determined and approved the performance metrics, which are based on the achievement of certain total shareholder return results, as measured against certain stock price hurdles (the “Market Condition”); and (b) extended the vesting period of the PRSU Award through December 31, 2027. As an additional condition to vesting of each tranche of the PRSU Award, Mr. Siebel must remain in continuous service to the Company through a minimum service date that applies to such tranche or, if later, the date the applicable performance metric is achieved (the “Service Condition”). The grant date of the PRSU Award was established in December 2022. Stock-based compensation expense associated with the PRSU Award will be recognized over the longer of the expected achievement period for the Market Condition or the Service Condition. For the nine months ended January 31, 2024, the Company recorded stock-based compensation expense of $4.1 million related to the PRSU Award. The Company determined the grant date fair value of the PRSU Award using a Monte Carlo simulation model with the following assumptions: stock price of $12.90, risk-free interest rate of 3.7%, dividend yield of 0% and expected volatility of 51.4%. A summary of the Company’s RSU activity during the nine months ended January 31, 2024 is as follows: RSUs Outstanding Number of RSUs Weighted Average (in thousands) Unvested Balance as of April 30, 2023 21,146 $ 21.32 RSUs granted 7,974 33.67 RSUs vested (5,004) 25.27 RSUs forfeited (3,208) 25.72 Unvested Balance as of January 31, 2024 20,908 $ 24.83 As of January 31, 2024, there was $469.3 million of unrecognized stock-based compensation expense related to outstanding RSUs granted to employees that is expected to be recognized over a weighted-average period of 3.9 years. In June 2023 and 2022, the Compensation Committee approved the payment of fiscal year 2023 and 2022 bonuses, respectively, under the Company’s annual bonus program in the form of fully vested RSUs covering shares of Class A common stock to employees. The Company issued 532,842 and 811,790 shares of Class A common stock pursuant to this program in the nine months ended January 31, 2024 and 2023, respectively. Shares issued in settlement of fully vested RSUs granted under this bonus program were issued from the 2020 Incentive Plan and reduced the shares available for issuance under the 2020 Incentive Plan. Employee Stock Purchase Plan On November 27, 2020, the Company’s board of directors also adopted, and its stockholders also approved, the 2020 Employee Stock Purchase Plan (the “2020 ESPP”), which became effective immediately prior to the IPO. The 2020 ESPP authorizes the issuance of shares of Class A common stock pursuant to purchase rights granted to employees. A total of 3,000,000 shares of Class A common stock were initially reserved for future issuance under the 2020 ESPP. The number of shares of Class A common stock reserved for issuance under the 2020 ESPP is subject to automatic evergreen increases annually through (and including) May 1, 2030 pursuant to the terms of the 2020 ESPP. There was an automatic annual increase on May 1, 2023 in the number of shares reserved for future issuance pursuant to the 2020 ESPP in an amount equal to one percent (1%) of the total number of shares of the Company’s Class A common stock and Class B common stock outstanding on April 30, 2023. The 2020 ESPP permits participants to purchase shares of Class A common stock in an amount not exceeding 15% of their earnings during the relevant offering period. The offering dates and purchase dates for the 2020 ESPP are determined at the discretion of the Company’s board of directors. Except for the initial offering period under the 2020 ESPP, which commenced on October 16, 2022 and ends on September 15, 2024, the 2020 ESPP provides for 24-month offering periods beginning September 15 and March 15 of each year, with each offering period consisting of four six-month purchase periods. The 2020 ESPP allows eligible employees to purchase shares of the Company’s Class A common stock, subject to purchase limits of 2,500 shares during each six-month period or $25,000 worth of stock for each calendar year, through payroll deductions at price per share equal to 85% of the lesser of the fair market value of the Company’s Class A common stock on (i) the first trading day of the applicable offering period and (ii) the last trading day of each purchase period in the applicable offering period. If the price per share of the Company’s Class A common stock on any purchase date in the offering period is lower than the price per share of the Company’s Class A common stock price on the enrollment date of that offering period, the offering period will immediately reset after the purchase of shares on such purchase date and automatically roll into a new 24-month offering period. The Company uses a Black-Scholes-Merton option pricing model to determine the fair value of employee stock purchase rights granted under the 2020 ESPP. The following assumptions were used to calculate the fair value of shares to be granted under the 2020 ESPP during the period: Nine Months Ended January 31, 2024 2023 Valuation assumptions: Expected dividend yield — % — % Expected volatility 64.0 - 70.1% 47.8 - 61.4% Expected term (years) 0.5 - 2.0 0.4 - 1.9 Risk-free interest rate 5.0 - 5.5% 4.3 - 4.5% During the nine months ended January 31, 2024 and 2023, the Company recognized $4.3 million and $2.0 million, respectively, of stock-based compensation expense related to 2020 ESPP. As of January 31, 2024, there was $3.1 million of unrecognized stock-based compensation expense that is expected to be recognized over the remaining term of the respective offering periods. Stock-based Compensation Expense The following table summarizes the effects of stock-based compensation on the Company’s condensed consolidated statements of operations (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Cost of subscription $ 8,674 $ 5,996 $ 25,244 $ 15,754 Cost of professional services 309 361 1,248 1,911 Sales and marketing 17,528 18,316 52,533 54,175 Research and development 18,757 23,646 52,475 72,768 General and administrative 9,715 7,512 27,532 23,866 Total stock-based compensation expense $ 54,983 $ 55,831 $ 159,032 $ 168,474 The Company records stock-based compensation associated with the Company’s annual bonus program and retention bonus program for certain employees, which may be paid out in fully vested RSUs that are settled in shares of Class A common stock. During the nine months ended January 31, 2024, the Company recognized $25.5 million of stock-based compensation expense associated with these programs. As of January 31, 2024, $21.5 million was reflected under accrued compensation and employee benefits in the consolidated balance sheets. Upon settlement, this amount will be reflected under common stock and additional paid-in capital in the condensed consolidated statements of stockholders’ equity.

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Jan. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Accounting for income taxes for interim periods generally requires the provision for income taxes to be determined by applying an estimate of the annual effective tax rate for the full fiscal year to income or loss before income taxes, adjusted for discrete items, if any, for the reporting period. The Company updates its estimate of the annual effective tax rate each quarter and makes a cumulative adjustment in such period. The Company recorded income tax expense of $0.5 million and $0.1 million for the three months ended January 31, 2024 and 2023, respectively, and $0.9 million and $0.5 million for the nine months ended January 31, 2024 and 2023, respectively. Income tax expense consists primarily of income taxes in foreign jurisdictions in which the Company conducts business. Due to the Company’s history of losses in the United States, a full valuation allowance on substantially all of the Company’s deferred tax assets, including net operating loss carryforwards, research and development tax credits, and other book versus tax differences, was maintained.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	9 Months Ended
Net Loss Per Share Attributable to Common Stockholders	Jan. 31, 2024
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders Basic net loss per share was the same as diluted net loss per share for the periods presented because the Company was in a loss position for the three and nine months ended January 31, 2024 and 2023. For purposes of this calculation, stock options, RSUs, Class A common stock issuable in connection with the 2020 ESPP and early exercised stock options subject to repurchase are considered to be potential common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive. The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Numerator Net loss attributable to common stockholders $ (72,631) $ (63,162) $ (206,769) $ (203,883) Denominator Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted 120,486 110,735 118,259 108,869 Basic and diluted net loss per share attributable to common stockholders Basic and diluted net loss per Class A and Class B common shares $ (0.60) $ (0.57) $ (1.75) $ (1.87) The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the period presented because including them would have had an antidilutive effect were as follows (in thousands): As of January 31, 2024 2023 Stock options 32,103 35,774 RSUs 20,908 19,919 ESPP 1,102 —

Related Party Transactions

Related Party Transactions	9 Months Ended
Related Party Transactions	Jan. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Revenue Transactions with Baker Hughes Company In June 2019, the Company entered into multiple agreements with Baker Hughes under which Baker Hughes received a three-year subscription to use the Company’s software. This arrangement was revised in June 2020 to extend the term to five years and modify the subscription fees due. Under the agreements as revised in June 2020, Baker Hughes made minimum, non-cancellable revenue commitments, inclusive of their direct subscription fees and third-party revenue generated through a joint marketing arrangement with Baker Hughes in the amount of $46.7 million in fiscal year 2020, $53.3 million in fiscal year 2021, $75.0 million in fiscal year 2022, $125.0 million in fiscal year 2023, and $150.0 million in fiscal year 2024. The Company also agreed to pay Baker Hughes a sales commission on subscriptions and services offerings it resold in excess of the minimum revenue commitments. The Company and Baker Hughes again revised this arrangement in October 2021 to extend the term by an additional year, for a total of six years, with an expiration date in the fiscal year ending April 30, 2025, to modify the amount of Baker Hughes’ annual commitments to $85.0 million in fiscal year 2023, $110.0 million in fiscal year 2024, and $125.0 million in fiscal year 2025, and to revise the structure of the arrangement to simplify the sales process for Baker Hughes. Beginning in the fiscal year ended April 30, 2023, Baker Hughes’ annual commitments were reduced by any revenue the Company generates from certain customers. Known and estimable revenue from certain customers related to the arrangement is a form of variable consideration, which was determined at contract inception and reduced the revenue recognized from the arrangement. The Company acknowledged that Baker Hughes had met its minimum annual revenue commitment for the fiscal year 2022 and recognized $16.0 million of sales commission as deferred costs during the fiscal quarter ended October 31, 2021 related to this arrangement, which will be amortized over an expected period of five years. The Company and Baker Hughes again revised and expanded the agreements in January 2023. Pursuant to this revised arrangement, the frequency of payments due from Baker Hughes to the Company was accelerated, Baker Hughes obtained expanded reseller rights, and the Company agreed to provide additional products and services. This results in an increase of the overall transaction price of the arrangement by eliminating potential variable consideration attributable to any revenue the Company generated from certain customers. The amount of consideration to the Company may increase if Baker Hughes exceeds certain thresholds. The Company also provided Baker Hughes the option to extend the subscription term upon payment of a renewal fee. Pursuant to the January 2023 revised agreement, the transaction price of the Baker Hughes arrangement is not impacted by revenue the Company recognizes from certain customers in the oil and gas field. Baker Hughes ceased to qualify as a related party of the Company as of June 30, 2023 and the amounts disclosed related to them are accordingly presented only for the periods in which they were considered a related party. The Company recognized subscription revenue from direct subscription fees from Baker Hughes of $10.6 million and $55.9 million during the nine months ended January 31, 2024 and 2023, respectively, and $20.3 million during the three months ended January 31, 2023. The Company recognized professional services revenue from Baker Hughes of $5.8 million and $8.7 million during the nine months ended January 31, 2024 and 2023, respectively, and $8.6 million during the three months ended January 31, 2023. The Company recognized sales and marketing expenses related to Baker Hughes of $0.8 million and $10.5 million (inclusive of amortization of $0.8 million and $3.6 million, respectively, of deferred commissions) during the nine months ended January 31, 2024 and 2023, respectively. The Company recognized sales and marketing expenses related to Baker Hughes of $3.5 million (inclusive of amortization of $1.2 million of deferred commissions) during the three months ended January 31, 2023. The Company paid sales commission of nil and $16.0 million during the nine months ended January 31, 2024 and 2023, respectively, related to this arrangement. Sublease Arrangement On February 21, 2023, the Company entered into a sublease agreement (the “Sublease”) with First Virtual Group, Inc. (the “Subtenant”), whereby the Company agreed to sublease to the Subtenant approximately 3,130 square feet of space located in Redwood City, California (the “Subleased Space”). The Company previously entered into a lease (the “Original Lease”) with DWF IV 1400-1500 Seaport Blvd, LLC dated August 25, 2021 for approximately 283,013 square feet of office space split between two office towers, including the Subleased Space. Thomas M. Siebel, Chief Executive Officer and Chairman of the Company, serves as Chairman of the Subtenant. The term of the Sublease commenced on February 1, 2023. The Sublease was automatically renewed on October 1, 2023 and will be automatically renewed for successive one year periods thereafter unless the Subtenant notifies the Company of its election to terminate the Sublease, up to the expiration date of the Original Lease. The monthly base rent for the Sublease is equal to the rate per square foot paid by the Company as stated in the Original Lease. The monthly base rent the Subtenant pays was approximately $8,608 through September 30, 2023, increasing annually thereafter. In addition to base rent, the Subtenant is responsible for its allocated share of costs incurred and expenditures made by the Company in the operation and management of the Subleased Space.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Pay vs Performance Disclosure
Net loss	$ (72,631)	$ (63,162)	$ (206,769)	$ (203,883)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
Insider Trading Arrangements	Jan. 31, 2024 shares	Jan. 31, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Condoleezza Rice [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		During our last fiscal quarter, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of our securities set forth in the table below. Name and Position Action Date Rule 10b5-1* Non-Rule 10b5-1** Total Shares of Common Stock to be Sold Total Shares of Common Stock to be Purchased Expiration Date Condoleezza Rice Director Adoption December 28, 2023 X 75,001 — April 1, 2025 * Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. ** “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.
Name	Condoleezza Rice
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 28, 2023
Arrangement Duration	460 days
Aggregate Available	75,001	75,001

Summary of Business and Signi_2

Summary of Business and Significant Accounting Policies (Policies)	9 Months Ended
	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation and Principles of Consolidation The Company prepares its unaudited condensed consolidated financial statements in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2023, which was filed with the SEC on June 22, 2023. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the Company’s financial position as of January 31, 2024 and the results of operations for the three and nine months ended January 31, 2024. The results of operations for the three and nine months ended January 31, 2024 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period.
Principles of Consolidation	The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the accompanying unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about future events. These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, disclosures about contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results and outcomes could differ significantly from the Company’s estimates, judgments, and assumptions. Significant estimates include, but are not limited to, determining standalone selling price for performance obligations in contracts with customers and estimating variable consideration, the estimated expected benefit period for deferred contract acquisition costs, the useful lives of long-lived assets, the incremental borrowing rate for operating leases, other assumptions used to measure stock-based compensation, and the valuation of deferred income tax assets and uncertain tax positions. These estimates and assumptions are based on management’s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.
Fiscal Year	Fiscal Year The Company’s fiscal year ends on April 30.
Recently Issued Accounting Standards Not Yet Adopted	Recently Issued Accounting Standards Not Yet Adopted In November 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”) to improve the disclosures regarding a public entity’s reportable segments and address requests from investors for additional, more detailed information about a reportable segment’s expenses. The Company is required to adopt the guidance in the fourth quarter of fiscal 2025, though early adoption is permitted. The Company is currently evaluating the impact of this amendment on its Consolidated Financial Statements. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures (“ASU 2023-09”) to provide disaggregated income tax disclosures on rate reconciliation and income taxes paid. The Company is required to adopt the guidance in the fourth quarter of fiscal 2026, though early adoption is permitted. The Company is currently evaluating the impact of this amendment on its Consolidated Financial Statements.

Revenue (Tables)

Revenue (Tables)	9 Months Ended
Revenue (Tables)	Jan. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Revenue by Geographical Region	The following table presents revenue by geographical region (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 North America (1) $ 68,356 $ 55,254 $ 191,247 $ 155,108 Europe, the Middle East and Africa (1) 9,040 9,546 29,205 32,138 Asia Pacific (1) 952 1,801 2,877 6,603 Rest of World (1) 53 68 663 536 Total revenue $ 78,401 $ 66,669 $ 223,992 $ 194,385 __________________ (1) The United States comprised 86% and 83% of the Company’s revenue for the three months ended January 31, 2024 and 2023, respectively, and 85% and 80% of the Company’s revenue for the nine months ended January 31, 2024 and 2023, respectively. No other country comprised 10% or greater of the Company’s revenue for the three and nine months ended January 31, 2024 or 2023.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Jan. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Assets Measured at Fair Value on a Recurring Basis	The following table summarizes the types of assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands): As of January 31, 2024 As of April 30, 2023 Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 78,747 $ — $ — $ 78,747 $ 75,293 $ — $ — $ 75,293 Certificates of deposit — 3,500 — 3,500 — 2,000 — 2,000 Commercial paper — 8,925 — 8,925 — 112,851 — 112,851 Corporate debt securities — 1,893 — 1,893 — — — — Available-for-sale marketable securities: U.S. treasury securities — 7,455 — 7,455 — 27,397 — 27,397 Certificates of deposit — 65,514 — 65,514 — 61,025 — 61,025 U.S. government agencies securities — 57,763 — 57,763 — 75,674 — 75,674 Commercial paper — 161,222 — 161,222 — 184,230 — 184,230 Corporate debt securities — 316,807 — 316,807 — 179,247 — 179,247 Total cash equivalents and available-for-sale marketable securities $ 78,747 $ 623,079 $ — $ 701,826 $ 75,293 $ 642,424 $ — $ 717,717

Cash Equivalents and Marketab_2

Cash Equivalents and Marketable Securities (Tables)	9 Months Ended
Cash Equivalents and Marketable Securities (Tables)	Jan. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Available-For-Sale Debt Securities and Balance Sheet Classification	The following table summarizes the Company’s cash equivalents and available-for-sale marketable securities (in thousands): As of January 31, 2024 As of April 30, 2023 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cash equivalents: Money market funds $ 78,747 $ — $ — $ 78,747 $ 75,293 $ — $ — $ 75,293 Certificates of deposit 3,500 — — 3,500 2,000 — — 2,000 Commercial paper 8,925 — — 8,925 112,851 — — 112,851 Corporate debt securities 1,893 — — 1,893 — — — — Available-for-sale marketable securities: U.S. treasury securities 7,454 1 — 7,455 27,445 1 (49) 27,397 Certificates of deposit 65,514 — — 65,514 61,025 — — 61,025 U.S. government agencies securities 57,629 147 (13) 57,763 75,650 111 (87) 75,674 Commercial paper 161,222 — — 161,222 184,230 — — 184,230 Corporate debt securities 316,512 450 (155) 316,807 179,608 115 (476) 179,247 Total cash equivalents and available-for-sale marketable securities $ 701,396 $ 598 $ (168) $ 701,826 $ 718,102 $ 227 $ (612) $ 717,717
Summary of Available-For-Sale Debt Securities by Contractual Maturity	The following table summarizes the Company’s available-for-sale marketable securities by contractual maturity (in thousands): As of January 31, 2024 As of April 30, 2023 Amortized Cost Fair Value Amortized Cost Fair Value Within one year $ 518,581 $ 518,683 $ 446,629 $ 446,155 After one year through five years 89,750 90,078 81,329 81,418 Total $ 608,331 $ 608,761 $ 527,958 $ 527,573
Summary of Available-For-Sale Marketable Securities, Fair Values and Unrealized Losses	The following table summarizes the fair values and unrealized losses of the Company’s available-for-sale marketable securities classified by length of time that the securities have been in a continuous unrealized loss position but were not deemed to be other-than-temporarily impaired, as of January 31, 2024 (in thousands): As of January 31, 2024 Less Than 12 Months 12 Months or Greater Total Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value U.S. government agencies securities $ (9) $ 17,968 $ (4) $ 2,362 $ (13) $ 20,330 Commercial paper — 5,953 — — — 5,953 Corporate debt securities (133) 120,053 (22) 10,710 (155) 130,763 Total $ (142) $ 143,974 $ (26) $ 13,072 $ (168) $ 157,046

Balance Sheet Details (Tables)

Balance Sheet Details (Tables)	9 Months Ended
Balance Sheet Details (Tables)	Jan. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Property and Equipment, Net	Property and equipment consisted of the following at January 31, 2024 and April 30, 2023 (in thousands): Useful Life As of January 31, As of April 30, (in months) 2024 2023 Leasehold improvements * $ 71,703 $ 66,522 Computer equipment 36 5,620 4,901 Office furniture and equipment 60 14,494 14,343 Capital in progress NA 12,042 3,140 Property and equipment, gross 103,859 88,906 Less: accumulated depreciation and amortization (12,856) (4,328) Property and equipment, net $ 91,003 $ 84,578 __________________ * Leasehold improvements are amortized over the shorter of the estimated useful lives of the improvements or the remaining lease term. NA = Not Applicable
Schedule of Accrued Compensation and Employee Benefits	Accrued compensation and employee benefits consisted of the following at January 31, 2024 and April 30, 2023 (in thousands): As of January 31, As of April 30, 2024 2023 Accrued stock-settled bonus $ 21,522 $ 32,414 Accrued bonus 296 186 Accrued vacation 3,948 4,602 Accrued payroll taxes and benefits 3,166 3,975 Accrued commissions 3,181 2,889 Accrued salaries 414 206 ESPP contributions 4,383 1,339 Other 912 902 Accrued compensation and employee benefits $ 37,822 $ 46,513
Schedule of Accrued and Other Current Liabilities	Accrued and other current liabilities consisted of the following at January 31, 2024 and April 30, 2023 (in thousands): As of January 31, As of April 30, 2024 2023 Liability for common stock exercised prior to vesting $ 385 $ 799 Accrued general expenses 3,131 5,541 Operating lease liabilities, current 2,936 2,339 Accrued professional services 2,286 2,889 Commissions payable to a related party — 2,448 Other 3,653 3,054 Accrued and other current liabilities $ 12,391 $ 17,070

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
Stock-Based Compensation (Tables)	Jan. 31, 2024
Share-Based Payment Arrangement [Abstract]
Summary of Stock Option Activity	A summary of the Company’s option activity during the nine months ended January 31, 2024 is as follows: Options Outstanding Number of Weighted Weighted Aggregate (in thousands) (in thousands) Balance as of April 30, 2023 34,696 $ 12.75 6.45 $ 175,907 Options granted 829 30.11 Options exercised (2,535) 34.48 Options cancelled (953) 10.74 Balance as of January 31, 2024 32,037 $ 13.91 5.90 $ 348,241 Vested and exercisable as of January 31, 2024 23,395 $ 10.30 5.42 $ 338,766 Vested and expected to vest as of January 31, 2024 (1) 32,103 $ 13.91 5.90 $ 348,956 __________________ (1) The number of options vested and expected to vest as of January 31, 2024 includes early exercised, unvested Class A common stock. Refer to Note 7. Stockholders’ Equity for more information.
Schedule of Valuation Assumptions	The weighted average assumptions underlying the fair value estimation are provided in the following table: Nine Months Ended January 31, 2024 2023 Valuation assumptions: Expected dividend yield — % — % Expected volatility 63.5 % 46.2 % Expected term (years) 6.0 6.5 Risk-free interest rate 3.9 % 3.8 %
Schedule of Restricted Stock Unit Activity	A summary of the Company’s RSU activity during the nine months ended January 31, 2024 is as follows: RSUs Outstanding Number of RSUs Weighted Average (in thousands) Unvested Balance as of April 30, 2023 21,146 $ 21.32 RSUs granted 7,974 33.67 RSUs vested (5,004) 25.27 RSUs forfeited (3,208) 25.72 Unvested Balance as of January 31, 2024 20,908 $ 24.83
Schedule of Valuation Assumptions, ESPP	The following assumptions were used to calculate the fair value of shares to be granted under the 2020 ESPP during the period: Nine Months Ended January 31, 2024 2023 Valuation assumptions: Expected dividend yield — % — % Expected volatility 64.0 - 70.1% 47.8 - 61.4% Expected term (years) 0.5 - 2.0 0.4 - 1.9 Risk-free interest rate 5.0 - 5.5% 4.3 - 4.5%
Summary of Effects of Stock-Based Compensation	The following table summarizes the effects of stock-based compensation on the Company’s condensed consolidated statements of operations (in thousands): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Cost of subscription $ 8,674 $ 5,996 $ 25,244 $ 15,754 Cost of professional services 309 361 1,248 1,911 Sales and marketing 17,528 18,316 52,533 54,175 Research and development 18,757 23,646 52,475 72,768 General and administrative 9,715 7,512 27,532 23,866 Total stock-based compensation expense $ 54,983 $ 55,831 $ 159,032 $ 168,474

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Jan. 31, 2024
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss Per Share	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share data): Three Months Ended January 31, Nine Months Ended January 31, 2024 2023 2024 2023 Numerator Net loss attributable to common stockholders $ (72,631) $ (63,162) $ (206,769) $ (203,883) Denominator Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted 120,486 110,735 118,259 108,869 Basic and diluted net loss per share attributable to common stockholders Basic and diluted net loss per Class A and Class B common shares $ (0.60) $ (0.57) $ (1.75) $ (1.87)
Schedule of Potential Shares of Common Stock Excluded from Computation of Basic and Diluted Net Loss Per Share	The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the period presented because including them would have had an antidilutive effect were as follows (in thousands): As of January 31, 2024 2023 Stock options 32,103 35,774 RSUs 20,908 19,919 ESPP 1,102 —

Revenue - Disaggregated Revenue

Revenue - Disaggregated Revenue by Geographic Region (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Disaggregation of Revenue [Line Items]
Total revenue	$ 78,401	$ 66,669	$ 223,992	$ 194,385
North America
Disaggregation of Revenue [Line Items]
Total revenue	$ 68,356	$ 55,254	$ 191,247	$ 155,108
United States \| Revenue \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Geographic concentration risk, percentage	86%	83%	85%	80%
Europe, the Middle East and Africa
Disaggregation of Revenue [Line Items]
Total revenue	$ 9,040	$ 9,546	$ 29,205	$ 32,138
Asia Pacific
Disaggregation of Revenue [Line Items]
Total revenue	952	1,801	2,877	6,603
Rest of World
Disaggregation of Revenue [Line Items]
Total revenue	$ 53	$ 68	$ 663	$ 536

Revenue - Deferred Revenue (Det

Revenue - Deferred Revenue (Details) - USD ($) $ in Millions	9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Apr. 30, 2023
Revenue from Contract with Customer [Abstract]
Contract with customer, liability	$ 41.3		$ 47.9
Revenue recognized	$ 46.3	$ 45.6

Revenue - Remaining Performance

Revenue - Remaining Performance Obligation (Details) $ in Millions	Jan. 31, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations, amount	$ 286.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized from remaining performance obligations, amount	$ 172
Revenue expected to be recognized from remaining performance obligations, period	12 months

Revenue - Customer Concentratio

Revenue - Customer Concentration and Accounts Receivable (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023	Apr. 30, 2023
Disaggregation of Revenue [Line Items]
Unbilled receivables	$ 102.6		$ 102.6		$ 77.6
Customer Concentration Risk \| Revenue \| Customer One
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage	25%	45%	27%	34%
Customer Concentration Risk \| Revenue \| Customer Two
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage	12%		13%
Customer Concentration Risk \| Accounts Receivable \| Customer One
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage			18%		20%
Customer Concentration Risk \| Accounts Receivable \| Customer Two
Disaggregation of Revenue [Line Items]
Customer concentration risk, percentage			14%		18%

Fair Value Measurements - Asset

Fair Value Measurements - Assets Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	$ 701,826	$ 717,717
Money market funds
Cash equivalents:
Estimated Fair Value	78,747	75,293
Certificates of deposit
Cash equivalents:
Estimated Fair Value	3,500	2,000
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	65,514	61,025
Commercial paper
Cash equivalents:
Estimated Fair Value	8,925	112,851
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	161,222	184,230
Corporate debt securities
Cash equivalents:
Estimated Fair Value	1,893	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	316,807	179,247
U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	7,455	27,397
U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	57,763	75,674
Fair Value, Recurring
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	701,826	717,717
Fair Value, Recurring \| Money market funds
Cash equivalents:
Estimated Fair Value	78,747	75,293
Fair Value, Recurring \| Certificates of deposit
Cash equivalents:
Estimated Fair Value	3,500	2,000
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	65,514	61,025
Fair Value, Recurring \| Commercial paper
Cash equivalents:
Estimated Fair Value	8,925	112,851
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	161,222	184,230
Fair Value, Recurring \| Corporate debt securities
Cash equivalents:
Estimated Fair Value	1,893	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	316,807	179,247
Fair Value, Recurring \| U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	7,455	27,397
Fair Value, Recurring \| U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	57,763	75,674
Fair Value, Recurring \| Level 1
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	78,747	75,293
Fair Value, Recurring \| Level 1 \| Money market funds
Cash equivalents:
Estimated Fair Value	78,747	75,293
Fair Value, Recurring \| Level 1 \| Certificates of deposit
Cash equivalents:
Estimated Fair Value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring \| Level 1 \| Commercial paper
Cash equivalents:
Estimated Fair Value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring \| Level 1 \| Corporate debt securities
Cash equivalents:
Estimated Fair Value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring \| Level 1 \| U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring \| Level 1 \| U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring \| Level 2
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	623,079	642,424
Fair Value, Recurring \| Level 2 \| Money market funds
Cash equivalents:
Estimated Fair Value	0	0
Fair Value, Recurring \| Level 2 \| Certificates of deposit
Cash equivalents:
Estimated Fair Value	3,500	2,000
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	65,514	61,025
Fair Value, Recurring \| Level 2 \| Commercial paper
Cash equivalents:
Estimated Fair Value	8,925	112,851
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	161,222	184,230
Fair Value, Recurring \| Level 2 \| Corporate debt securities
Cash equivalents:
Estimated Fair Value	1,893	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	316,807	179,247
Fair Value, Recurring \| Level 2 \| U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	7,455	27,397
Fair Value, Recurring \| Level 2 \| U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	57,763	75,674
Fair Value, Recurring \| Level 3
Available-for-sale marketable securities:
Total cash equivalents and available-for-sale marketable securities	0	0
Fair Value, Recurring \| Level 3 \| Money market funds
Cash equivalents:
Estimated Fair Value	0	0
Fair Value, Recurring \| Level 3 \| Certificates of deposit
Cash equivalents:
Estimated Fair Value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring \| Level 3 \| Commercial paper
Cash equivalents:
Estimated Fair Value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring \| Level 3 \| Corporate debt securities
Cash equivalents:
Estimated Fair Value	0	0
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring \| Level 3 \| U.S. treasury securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	0	0
Fair Value, Recurring \| Level 3 \| U.S. government agencies securities
Available-for-sale marketable securities:
Available-for-sale marketable securities, fair value	$ 0	$ 0

Cash Equivalents and Marketab_3

Cash Equivalents and Marketable Securities - Available-for-Sale Marketable Securities (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023	Jan. 31, 2023
Cash equivalents:
Amortized Cost	$ 114,561	$ 284,829	$ 311,142
Debt Securities, Available-for-Sale [Abstract]
Total cash equivalents and available-for-sale marketable securities, Amortized Cost	701,396	718,102
Total cash equivalents and available-for-sale marketable securities, Gross Unrealized Gain	598	227
Total cash equivalents and available-for-sale marketable securities, Gross Unrealized Loss	(168)	(612)
Total cash equivalents and available-for-sale marketable securities	701,826	717,717
Money market funds
Cash equivalents:
Amortized Cost	78,747	75,293
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	78,747	75,293
Certificates of deposit
Cash equivalents:
Amortized Cost	3,500	2,000
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	3,500	2,000
Debt Securities, Available-for-Sale [Abstract]
Amortized Cost	65,514	61,025
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	65,514	61,025
Commercial paper
Cash equivalents:
Amortized Cost	8,925	112,851
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	8,925	112,851
Debt Securities, Available-for-Sale [Abstract]
Amortized Cost	161,222	184,230
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	161,222	184,230
Corporate debt securities
Cash equivalents:
Amortized Cost	1,893	0
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	1,893	0
Debt Securities, Available-for-Sale [Abstract]
Amortized Cost	316,512	179,608
Gross Unrealized Gains	450	115
Gross Unrealized Losses	(155)	(476)
Estimated Fair Value	316,807	179,247
U.S. treasury securities
Debt Securities, Available-for-Sale [Abstract]
Amortized Cost	7,454	27,445
Gross Unrealized Gains	1	1
Gross Unrealized Losses	0	(49)
Estimated Fair Value	7,455	27,397
U.S. government agencies securities
Debt Securities, Available-for-Sale [Abstract]
Amortized Cost	57,629	75,650
Gross Unrealized Gains	147	111
Gross Unrealized Losses	(13)	(87)
Estimated Fair Value	$ 57,763	$ 75,674

Cash Equivalents and Marketab_4

Cash Equivalents and Marketable Securities - Available-for Sale Debt Securities by Contractual Maturity (Details) - Debt Securities, Available-For-Sale, Excluding Money Market Accounts - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023
Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]
AFS Debt Maturities, Within one year, Amortized Cost	$ 518,581	$ 446,629
AFS Debt Maturities, After one year through five years, Amortized Cost	89,750	81,329
Amortized Cost	608,331	527,958
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
AFS Debt Maturities, Within one year, Fair Value	518,683	446,155
AFS Debt Maturities, After one year through five years, Fair Value	90,078	81,418
AFS Debt Maturities, Total Fair Value	$ 608,761	$ 527,573

Cash Equivalents and Marketab_5

Cash Equivalents and Marketable Securities - Available-for-Sale Marketable Securities, Fair Value and Unrealized Losses Continuous Unrealized Loss Position (Details) $ in Thousands	Jan. 31, 2024 USD ($)
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
AFS, Less Than 12 Months, Unrealized Losses	$ (142)
AFS, Less Than 12 Months, Fair Value	143,974
AFS, 12 Months or Greater, Unrealized Losses	(26)
AFS, 12 Months or Greater, Fair Value	13,072
AFS, Total Unrealized Losses	(168)
AFS, Total Fair Value	157,046
U.S. government agencies securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
AFS, Less Than 12 Months, Unrealized Losses	(9)
AFS, Less Than 12 Months, Fair Value	17,968
AFS, 12 Months or Greater, Unrealized Losses	(4)
AFS, 12 Months or Greater, Fair Value	2,362
AFS, Total Unrealized Losses	(13)
AFS, Total Fair Value	20,330
Commercial paper
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
AFS, Less Than 12 Months, Unrealized Losses	0
AFS, Less Than 12 Months, Fair Value	5,953
AFS, 12 Months or Greater, Unrealized Losses	0
AFS, 12 Months or Greater, Fair Value	0
AFS, Total Unrealized Losses	0
AFS, Total Fair Value	5,953
Corporate debt securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
AFS, Less Than 12 Months, Unrealized Losses	(133)
AFS, Less Than 12 Months, Fair Value	120,053
AFS, 12 Months or Greater, Unrealized Losses	(22)
AFS, 12 Months or Greater, Fair Value	10,710
AFS, Total Unrealized Losses	(155)
AFS, Total Fair Value	$ 130,763

Cash Equivalents and Marketab_6

Cash Equivalents and Marketable Securities - Narrative (Details)	9 Months Ended
	Jan. 31, 2024 USD ($) marketable_security	Apr. 30, 2023 marketable_security
Investments, Debt and Equity Securities [Abstract]
Number of marketable securities in unrealized loss position \| marketable_security	130	119
Other-than-temporary impairment loss \| $	$ 0

Balance Sheet Details - Propert

Balance Sheet Details - Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 103,859	$ 88,906
Less: accumulated depreciation and amortization	(12,856)	(4,328)
Property and equipment, net	91,003	84,578
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 71,703	66,522
Computer equipment
Property, Plant and Equipment [Line Items]
Useful Life	36 months
Property and equipment, gross	$ 5,620	4,901
Office furniture and equipment
Property, Plant and Equipment [Line Items]
Useful Life	60 months
Property and equipment, gross	$ 14,494	14,343
Capital in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 12,042	$ 3,140

Balance Sheet Details - Narrati

Balance Sheet Details - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation expense	$ 2.9	$ 0.5	$ 8.5	$ 2.4

Balance Sheet Details - Accrued

Balance Sheet Details - Accrued Compensation and Employee Benefits (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued stock-settled bonus	$ 21,522	$ 32,414
Accrued bonus	296	186
Accrued vacation	3,948	4,602
Accrued payroll taxes and benefits	3,166	3,975
Accrued commissions	3,181	2,889
Accrued salaries	414	206
ESPP contributions	4,383	1,339
Other	912	902
Accrued compensation and employee benefits	$ 37,822	$ 46,513

Balance Sheet Details - Accru_2

Balance Sheet Details - Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands		Jan. 31, 2024	Apr. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liability for common stock exercised prior to vesting		$ 385	$ 799
Accrued general expenses		3,131	5,541
Operating lease liabilities, current		2,936	2,339
Accrued professional services		2,286	2,889
Commissions payable to a related party		0	2,448
Other		3,653	3,054
Accrued and other current liabilities	[1]	$ 12,391	$ 17,070

[1]Including amounts due to a related party of $2,448 as of April 30, 2023.

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions

1 Months Ended

3 Months Ended

9 Months Ended

11 Months Ended

Feb. 15, 2023 officer_and_director plaintiff

Jan. 31, 2024 USD ($) phase

Oct. 31, 2023 USD ($)

Jul. 31, 2022 USD ($)

Feb. 29, 2020

Jan. 31, 2024 USD ($) phase

Jul. 31, 2023 USD ($)

Jan. 31, 2023 USD ($)

Jan. 31, 2024 USD ($) phase

Jan. 31, 2023 USD ($)

Apr. 19, 2023 claim

Apr. 30, 2023 USD ($) phase

Oct. 31, 2022 phase

Jan. 31, 2022 phase

Aug. 25, 2021 ft²

Long-term Purchase Commitment [Line Items]

Lease, area under lease | ft²

283,015

Lease, number of phases | phase

Operating lease, liability

$ 47.4

$ 2

$ 47.4

Operating lease, right-of-use assets

17.2

1.7

17.2

Decrease in right-of-use asset

1.7

1.6

Decrease in lease liability

1.7

$ 1.6

The Reckstin Family Trust v. C3.ai, Inc. | Settled Litigation

Long-term Purchase Commitment [Line Items]

Number of additional plaintiffs | plaintiff

Number of current and former officers and directors | officer_and_director

Suri V. Siebel Et Al., Rabasca V. Siebel Et Al. And Vo V. Siebel Et Al | Pending Litigation

Long-term Purchase Commitment [Line Items]

Number of actions filed | claim

C3.ai DTI Grants Program

Long-term Purchase Commitment [Line Items]

Grants, payment period

5 years

Grants, potential remaining contributions

31.6

$ 31.6

Cloud Services, July 2022-July 2025

Long-term Purchase Commitment [Line Items]

Purchase commitment, at least

$ 100

Purchase commitment, term

3 years

Purchase commitment, incurred cost

7.7

$ 2.3

23.5

$ 3.9

Professional Services, October 2023-April 2025

Long-term Purchase Commitment [Line Items]

Purchase commitment, at least

$ 15

Purchase commitment, term

18 months

Purchase commitment, incurred cost

0.2

Professional Services, January 2024-January 2025

Long-term Purchase Commitment [Line Items]

Purchase commitment, at least

$ 13

Purchase commitment, incurred cost

$ 0.7

$ 1.2

Stockholders' Equity (Details)

Stockholders' Equity (Details)	1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
Stockholders' Equity (Details)	Mar. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($)	Jan. 31, 2024 USD ($) vote $ / shares shares	Jan. 31, 2023 USD ($)	Jan. 31, 2024 USD ($) vote $ / shares shares	Jan. 31, 2023 USD ($)	Apr. 30, 2023 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Preferred stock, shares authorized (in shares)			200,000,000		200,000,000
Preferred stock, par value (in dollars per share) \| $ / shares			$ 0.001		$ 0.001
Preferred stock, shares issued (in shares)			0		0
Preferred stock, shares outstanding (in shares)			0		0
Automatic conversion period, following the death or incapacity of Mr. Siebel					6 months
Automatic conversion period, following the date Mr. Siebel no longer providing services					6 months
Automatic conversion, anniversary period, if circumstances met					20 years
Net proceeds common stock exercised prior to vesting \| $			$ 0	$ 0	$ 0	$ 0
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares subject to repurchase right (in shares)					65,730		148,239
Class A Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)			1,000,000,000		1,000,000,000
Voting rights, number of votes for each share \| vote			1		1
Common stock, par value (in dollars per share) \| $ / shares			$ 0.001		$ 0.001
Stock repurchase program, authorized amount (up to) \| $		$ 100,000,000
Stock repurchase program, repurchase period		18 months
Repurchase and retirement of Class A common stock (in shares)	700,000
Repurchase and retirement of Class A common stock, value \| $	$ 15,000,000
Stock repurchase program, shares repurchased (in shares)					0
Class B Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, shares authorized (in shares)			3,500,000		3,500,000
Voting rights, number of votes for each share \| vote			50		50
Common stock, par value (in dollars per share) \| $ / shares			$ 0.001		$ 0.001

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
	Nov. 27, 2020 USD ($) period shares	Jan. 31, 2024 USD ($) $ / shares	Jan. 31, 2023 USD ($)	Jan. 31, 2024 USD ($) $ / shares shares	Jan. 31, 2023 USD ($) shares	Oct. 04, 2023	May 01, 2023	Apr. 30, 2023 USD ($)	Jul. 31, 2022 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense		$ 54,983	$ 55,831	$ 159,032	$ 168,474
Risk-free interest rate				3.90%	3.80%
Expected dividend yield				0%	0%
Expected volatility				63.50%	46.20%
Accrued stock-settled bonus		21,522		$ 21,522				$ 32,414
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost		90,800		$ 90,800
Unrecognized compensation cost, weighted-average recognition period				2 years 6 months
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period				5 years
Unrecognized compensation cost, weighted-average recognition period				3 years 10 months 24 days
Unrecognized stock-based compensation expense		$ 469,300		$ 469,300
Granted, non-option (in shares) \| shares				7,974,000
RSUs \| Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentages				20%
Vesting period				1 year
RSUs \| Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentages				5%
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum shares authorized (in shares) \| shares									1,700,000
Total stock-based compensation expense				$ 4,100
Stock price (in dollars per share) \| $ / shares		$ 12.90		$ 12.90
Risk-free interest rate				3.70%
Expected dividend yield				0%
Expected volatility				51.40%
2020 Incentive Plan \| Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period (in years)				10 years
2020 Incentive Plan \| Stock options \| Share-Based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentages				20%
Vesting period				1 year
2020 Incentive Plan \| Stock options \| Share-Based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentages				2%
Vesting period				4 years
2020 Employee Stock Purchase Plan \| ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense				$ 4,300	$ 2,000
Expected dividend yield				0%	0%
Unrecognized stock-based compensation expense		$ 3,100		$ 3,100
Percentage of employee earnings participation (up to)	15%
Initial offering period (in months)	24 months
Number of purchase periods \| period	4
Purchase period (in months)	6 months
Annual Bonus Program And Retention Bonus Program \| RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense				$ 25,500
Common Class A and Common Class B \| 2020 Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Automatic increase to shares reserved for future issuance, percent of total shares outstanding as of April 30, 2022						7%	5%
Common Class A and Common Class B \| 2020 Employee Stock Purchase Plan \| ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Automatic increase to shares reserved for future issuance, percent of total shares outstanding as of April 30, 2022							1%
Class A Common Stock \| Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, non-option (in shares) \| shares				532,842	811,790
Class A Common Stock \| 2020 Employee Stock Purchase Plan \| ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares) \| shares	3,000,000
Shares purchased (in shares) \| shares	2,500
Shares purchased	$ 25
Fair market value (as a percent)	85%

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Jan. 31, 2024 USD ($) $ / shares shares	Apr. 30, 2023 USD ($) $ / shares shares
Number of Stock Options Outstanding
Balance at beginning of period (in shares) \| shares	34,696
Options granted (in shares) \| shares	829
Options exercised (in shares) \| shares	(2,535)
Options cancelled (in shares) \| shares	(953)
Balance at end of period (in shares) \| shares	32,037	34,696
Vested and exercisable at end of period (in shares) \| shares	23,395
Vested and expected to vest at end of period (in shares) \| shares	32,103
Weighted Average Exercise Price
Balance at beginning of period (in dollars per share) \| $ / shares	$ 12.75
Options granted (in dollars per share) \| $ / shares	30.11
Options exercised (in dollars per share) \| $ / shares	34.48
Options cancelled (in dollars per share) \| $ / shares	10.74
Balance at end of period (in dollars per share) \| $ / shares	13.91	$ 12.75
Vested and exercisable at end of period (in dollars per share) \| $ / shares	10.30
Vested and expected to vest at end of period (in dollars per share) \| $ / shares	$ 13.91
Weighted Average Remaining Contractual Life (years)
Balance at beginning of period	5 years 10 months 24 days	6 years 5 months 12 days
Balance at end of period	5 years 10 months 24 days	6 years 5 months 12 days
Vested and exercisable at end of period	5 years 5 months 1 day
Vested and expected to vest at end of period	5 years 10 months 24 days
Aggregate Intrinsic Value
Balance at beginning of period \| $	$ 348,241	$ 175,907
Balance at end of period \| $	348,241	$ 175,907
Vested and exercisable at end of period \| $	338,766
Vested and expected to vest at end of period \| $	$ 348,956

Stock-Based Compensation - Valu

Stock-Based Compensation - Valuation Assumptions (Details)	9 Months Ended
Stock-Based Compensation - Valuation Assumptions (Details)	Jan. 31, 2024	Jan. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	0%	0%
Expected volatility	63.50%	46.20%
Expected term (years)	6 years	6 years 6 months
Risk-free interest rate	3.90%	3.80%
2020 Employee Stock Purchase Plan \| ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield	0%	0%
Expected volatility, minimum	64%	47.80%
Expected volatility, maximum	70.10%	61.40%
Risk-free interest rate, maximum	5.50%	4.50%
Risk-free interest rate, minimum	5%	4.30%
2020 Employee Stock Purchase Plan \| ESPP \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	6 months	4 months 24 days
2020 Employee Stock Purchase Plan \| ESPP \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)	2 years	1 year 10 months 24 days

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Unit Activity (Details) - RSUs shares in Thousands	9 Months Ended
	Jan. 31, 2024 $ / shares shares
Number of RSUs
Unvested Balance at beginning of period (in shares) \| shares	21,146
RSUs granted (in shares) \| shares	7,974
RSUs vested (in shares) \| shares	(5,004)
RSUs forfeited (in shares) \| shares	(3,208)
Unvested Balance at end of period (in shares) \| shares	20,908
Weighted Average Grant Date Fair Value Per Share
Unvested Balance at beginning of period (in dollars per share) \| $ / shares	$ 21.32
RSUs granted (in dollars per share) \| $ / shares	33.67
RSUs vested (in dollars per share) \| $ / shares	25.27
RSUs forfeited (in dollars per share) \| $ / shares	25.72
Unvested Balance at end of period (in dollars per share) \| $ / shares	$ 24.83

Stock-Based Compensation - St_2

Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 54,983	$ 55,831	$ 159,032	$ 168,474
Cost of revenue \| Subscription
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	8,674	5,996	25,244	15,754
Cost of revenue \| Professional services
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	309	361	1,248	1,911
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	17,528	18,316	52,533	54,175
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	18,757	23,646	52,475	72,768
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 9,715	$ 7,512	$ 27,532	$ 23,866

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 489	$ 143	$ 863	$ 485

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Numerator
Net loss attributable to common stockholders	$ (72,631)	$ (63,162)	$ (206,769)	$ (203,883)
Denominator
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic (in shares)	120,486	110,735	118,259	108,869
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)	120,486	110,735	118,259	108,869
Basic and diluted net loss per share attributable to common stockholders
Basic net loss per Class A and Class B common shares (in dollars per share)	$ (0.60)	$ (0.57)	$ (1.75)	$ (1.87)
Diluted net loss per Class A and Class B common shares (in dollars per share)	$ (0.60)	$ (0.57)	$ (1.75)	$ (1.87)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Potential Shares Excluded From Computation of Diluted Net Loss Per Share (Details) - shares shares in Thousands	9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially antidilutive shares excluded from computation of net loss per share (in shares)	32,103	35,774
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially antidilutive shares excluded from computation of net loss per share (in shares)	20,908	19,919
ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially antidilutive shares excluded from computation of net loss per share (in shares)	1,102	0

Related Party Transactions - Na

Related Party Transactions - Narrative (Details)			1 Months Ended			3 Months Ended		9 Months Ended
Related Party Transactions - Narrative (Details)		Feb. 21, 2023 USD ($) ft²	Oct. 31, 2021 USD ($)	Jun. 30, 2020 USD ($)	Jun. 30, 2019	Jan. 31, 2024 USD ($)	Jan. 31, 2023 USD ($)	Jan. 31, 2024 USD ($)	Jan. 31, 2023 USD ($)	Aug. 25, 2021 ft² office_tower
Related Party Transaction [Line Items]
Total revenue						$ 78,401,000	$ 66,669,000	$ 223,992,000	$ 194,385,000
Sales and marketing expenses	[1]					57,140,000	43,497,000	150,920,000	131,420,000
Subleased space area (in square feet) \| ft²		3,130								283,013
Number of office towers \| office_tower										2
Automatic renewal term (in years)		1 year
Monthly base rent		$ 8,608
Subscription
Related Party Transaction [Line Items]
Total revenue	[2]					70,400,000	57,043,000	198,201,000	173,577,000
Professional services
Related Party Transaction [Line Items]
Total revenue	[3]					$ 8,001,000	9,626,000	25,791,000	20,808,000
Related Party
Related Party Transaction [Line Items]
Sales and marketing expenses							3,515,000	810,000	10,546,000
Related Party \| Subscription
Related Party Transaction [Line Items]
Total revenue							20,316,000	10,581,000	55,884,000
Related Party \| Professional services
Related Party Transaction [Line Items]
Total revenue							8,599,000	5,804,000	8,749,000
Related Party \| Software Subscription Agreement \| Baker Hughes Company
Related Party Transaction [Line Items]
Revenue commitment, term			6 years	5 years	3 years
Revenue commitment, fiscal year 2020				$ 46,700,000
Revenue commitment, fiscal year 2021				53,300,000
Revenue commitment, fiscal year 2022				75,000,000
Revenue commitment, fiscal year 2023			$ 85,000,000	125,000,000
Revenue commitment, fiscal year 2024			110,000,000	$ 150,000,000
Revenue commitment, fiscal year 2025			125,000,000
Sales commissions, recognized as deferred costs			$ 16,000,000
Deferred costs, sales commissions, amortization period			5 years
Sales and marketing expenses							3,500,000	800,000	10,500,000
Deferred costs, sales commissions, amortization							1,200,000	800,000	3,600,000
Sales commissions paid								0	16,000,000
Related Party \| Software Subscription Agreement \| Baker Hughes Company \| Subscription
Related Party Transaction [Line Items]
Total revenue							20,300,000	10,600,000	55,900,000
Related Party \| Software Subscription Agreement \| Baker Hughes Company \| Professional services
Related Party Transaction [Line Items]
Total revenue							$ 8,600,000	$ 5,800,000	$ 8,700,000

[1]Including related party sales and marketing expense of $810 and $10,546 for the nine months ended January 31, 2024 and 2023, respectively, and $3,515 for the three months ended January 31, 2023.[2]Including related party revenue of $10,581 and $55,884 for the nine months ended January 31, 2024 and 2023, respectively, and $20,316 for the three months ended January 31, 2023.[3]Including related party revenue of $5,804 and $8,749 for the nine months ended January 31, 2024 and 2023, respectively, and $8,599 for the three months ended January 31, 2023.